InvestorsHub Logo
Followers 20
Posts 456
Boards Moderated 0
Alias Born 10/27/2012

Re: None

Wednesday, 09/27/2017 8:48:39 AM

Wednesday, September 27, 2017 8:48:39 AM

Post# of 1450
Valuation Sept 2017:
Oncocyte’s part is valued at 98M$
Asterias – 68M$
Agex (last funding) 58M$
BTX – 323M$
Hence Internal value is 99M$, buys you: OpRegen + Renevia and anything else in the future for free.
Let's say Opregen fails (we already have evidence it engrafts and is working).
Renevia has been proven to work clinically and will be selling by the end of 2018, into a massive market with no competition in the natural fat transfer universe. For 100M$ it is a steal.
Do your own DD… It is getting very simple to understand when to add...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTX News